Ligand-independent activity of the B cell antigen receptor in physiology and pathology

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 2, 2007, Pages 77-82

  Corcos, Daniel ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

B cell development; B cell receptor; Heavy chain diseases; Oncogenic growth factors; Signaling

Indexed keywords

B LYMPHOCYTE RECEPTOR;

CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; HUMAN; LIGAND BINDING; NONHUMAN; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; HEAVY CHAIN DISEASE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, B-CELL; LIGANDS; MICE; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 34147135621     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0010-1     Document Type: Review

References (55)

1. Alber G., Kim K. M., Weiser P., Riesterer C., Carsetti R. and Reth M. (1993): Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus. Curr. Biol., 3, 333-339.
2. Alt F. W., Enea V., Bothwell A. L. and Baltimore D. (1980): Activity of multiple light chain genes in murine myeloma cell producing a single, functional light chain. Cell, 21, 1-12.
3. Aoki Y., Isselbacher K. J., Cherayil B. J. and Pillai S. (1994): Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells. Proc. Natl. Acad. Sci. USA, 91, 4204-4208.
4. Arevalo J. C., Conde B., Hempstead B. L., Chao M. V., Martin-Zanca D. and Perez P. (2000): TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol. Cell Biol., 20, 5908-5916.
5. Bannish G., Fuentes-Panana E. M., Cambier J. C., Pear W. S. and Monroe J. G. (2001): Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med., 194, 1583-1596.
6. Blume-Jensen P. and Hunter T. (2001): Oncogenic kinase signalling. Nature, 411, 355-365.
7. Bradl H., Wittmann J., Milius D., Vettermann C. and Jack H. M. (2003): Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate. J. Immunol., 171, 2338-2348.
8. Caldwell R. G., Wilson J. B., Anderson S. J. and Longnecker R. (1998): Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity, 9, 405-411.
9. Cambier J. C. and Ransom J. T. (1987): Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu. Rev. Immunol., 5, 175-199.
10. Corcos D. (1990): Oncogenic potential of the B-cell antigen receptor and its relevance to heavy chain diseases and other B-cell neoplasias. Res. Immunol., 141, 543-553.
11. Corcos D. (2004): Signaling and cell surface expression of muH chains in the absence of light chains. J. Immunol., 172, 4-5.
12. Corcos D., Dunda O., Butor C., Cesbron J.-Y., Lores P., Bucchini D. and Jami J. (1995): Pre-B cell development in the absence of lambda-5 in transgenic mice expressing a heavy-chain disease protein. Curr. Biol., 5, 1140-1148.
13. Corcos D., Grandien A., Vazquez A., Dunda O., Lores P. and Bucchini D. (2001): Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells. J. Immunol., 166, 3083-3089.
14. Corcos D., Iglesias A., Dunda O., Bucchini D. and Jami J. (1991): Allelic exclusion in transgenic mice expressing a heavy chain disease-like human μ protein. Eur. J. Immunol., 21, 2711-2716.
15. Flemming A., Brummer T., Reth M. and Jumaa H. (2003): The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat. Immunol., 4, 38-43.
16. Fuentes-Panana E. M., Bannish G. and Monroe J. G. (2004): Basal B-cell receptor signaling in B lymphocytes: mechanisms of regulation and role in positive selection, differentiation, and peripheral survival. Immunol. Rev., 197, 26-40.
17. Fuentes-Panana E. M., Bannish G., Shah G. and Monroe J. G. (2004): Basal Igalpha/Igbeta signals trigger the coordinated initiation of pre-B cell antigen receptor-dependent processes. J. Immunol., 173, 1000-1011.
18. Fuentes-Panana E. M., Bannish G., van der Voort D., King L. B. and Monroe J. G. (2005): Ig alpha/Ig beta complexes generate signals for B cell development independent of selective plasma membrane compartmentalization. J. Immunol., 174, 1245-1252.
19. Galler G. R., Mundt C., Parker M., Pelanda R., Martensson I. L. and Winkler T. H. (2004): Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. J. Exp. Med., 199, 1523-1532.
20. Gaudin E., Hao Y., Rosado M. M., Chaby R., Girard R. and Freitas A. A. (2004): Positive selection of B cells expressing low densities of self-reactive BCRs. J. Exp. Med., 199, 843-853.
21. Gauld S. B., Dal Porto J. M. and Cambier J. C. (2002): B cell antigen receptor signaling: roles in cell development and disease. Science, 296, 1641-1642.
22. Gauthier L., Rossi B., Roux F., Termine E. and Schiff C. (2002): Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl. Acad. Sci. USA, 99, 13014-13019.
23. Gordon M. S., Kato R. M., Lansigan F., Thompson A. A., Wall R. and Rawlings D. J. (2000): Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells. Proc. Natl. Acad. Sci. USA, 97, 5504-5509.
24. Haas I. G. and Wabl M. (1983): Immunoglobulin heavy chain binding protein. Nature, 306, 387-389.
25. Hayakawa K., Asano M., Shinton S. A., Gui M., Allman D., Stewart C. L., Silver J. and Hardy R. R. (999): Positive selection of natural autoreactive B cells. Science, 285, 113-116.
26. Hombach J., Lottspeich F. and Reth M. (1990): Identification of the genes encoding the IgM-alpha and Ig-beta components of the IgM antigen receptor complex by amino-terminal sequencing. Eur. J. Immunol., 20, 2795-2799.
27. Huang H. S., Nagane M., Klingbeil C. K., Lin H., Nishikawa R., Ji X. D., Huang C. M., Gill G. N., Wiley H. S. and Cavenee W. K. (1997): The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem., 272, 2927-2935.
28. Jacobs H., Ossendorp F., de Vries E., Ungewiss K., von Boehmer H., Borst J. and Berns A. (1996): Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain. Oncogene, 12, 2089-2099.
29. Jumaa H., Bossaller L., Portugal K., Storch B., Lotz M., Flemming A., Schrappe M., Postila V., Riikonen P., Pelkonen J., Niemeyer C. M. and Reth M. (2003): Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature, 423, 452-456.
30. Jumaa H., Hendriks R. W. and Reth M. (2005): B cell signaling and tumorigenesis. Annu. Rev. Immunol., 23, 415-445.
31. Kinoshita K., Yamagata T., Nozaki Y., Sugiyama M., Ikoma S., Funauchi M. and Kanamaru A. (2004): Mu-heavy chain disease associated with systemic amyloidosis. Hematology, 9, 135-137.
32. Kitamura D., Kudo A., Schaal S., Müller W., Melchers F. and Rajewsky K. (1992): A critical role of l5 protein in B cell development. Cell, 69, 823-831.
33. Kraus M., Alimzhanov M. B., Rajewsky N. and Rajewsky K. (2004): Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell, 117, 787-800.
34. Kremyanskaya M. and Monroe J. G. (2005): Ig-independent Ig beta expression on the surface of B lymphocytes after B cell receptor aggregation. J. Immunol., 174, 1501-1506.
35. Kuppers R. (2003): B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol., 3, 801-812.
36. Lam K.-P., Kuhn R. and Rajewsky K. (1997): In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell, 90, 1073-1083.
37. Lee R. C., Walters J. A., Reyland M. E. and Anderson S. M. (1999): Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules. J. Biol. Chem., 274, 10024-10034.
38. Martin G. S. (1986): The erbB gene and the EGF receptor. Cancer Surv., 5, 199-219.
39. Melchers F., Karasuyama H., Haasner D., Bauer S., Kudo A., Sakaguchi N., Jameson B. and Rolink A. (1993): The surrogate light chain in B cell development. Immunol. Today, 14, 60-68.
40. Moscatello D. K., Montgomery R. B., Sundareshan P., McDanel H., Wong M. Y. and Wong A. J. (1996): Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene, 13, 85-96.
41. Nagata K., Nakamura T., Kitamura F., Kuramochi S., Taki S., Campbell K. S. and Karasuyama H. (1997): The Ig alpha/Igbeta heterodimer on mu-negative proB cells is competent for transducing signals to induce early B cell differentiation. Immunity, 7, 559-570.
42. Ohnishi K. and Melchers F. (2003): The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol., 4, 849-856.
43. Papavasiliou F., Jankovic M. and Nussenzweig M. C. (1996): Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition. J. Exp. Med., 184, 2025-2030.
44. Pelanda R., Schaal S., Torres R. M. and Rajewsky K. (1996): A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice. Immunity, 5, 229-239.
45. Reth M. (1992): Antigen receptors on B lymphocytes. Annu. Rev. Immunol., 10, 97-121.
46. Schamel W. W. and Reth M. (2000): Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity, 13, 5-14.
47. Schuh W., Meister S., Roth E. and Jack H. M. (2003): Cutting edge: signaling and cell surface expression of a micro H chain in the absence of lambda5: a paradigm revisited. J. Immunol., 171, 3343-3347.
48. Seligmann M., Mihaesco E., Preud'homme J.-L., Danon F. and Brouet J. C. (1979): Heavy chain diseases: current findings and concepts. Immunol.. Rev., 48, 145-167.
49. Shaffer A. L. and Schlissel M. S. (1997): A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development. J. Immunol., 159, 1265-1275.
50. Su Y. W., Flemming A., Wossning T., Hobeika E., Reth M. and Jumaa H. (2003): Identification of a pre-BCR lacking surrogate light chain. J. Exp. Med., 198, 1699-1706.
51. Tiegs S. L., Russell D. M. and Nemazee D. (1993): Receptor editing in self-reactive bone marrow B cells. J. Exp. Med., 177, 1009-1020.
52. Tze L. E., Schram B. R., Lam K. P., Hogquist K. A., Hippen K. L., Liu J., Shinton S. A., Otipoby K. L., Rodine P. R., Vegoe A. L., Kraus M., Hardy R. R., Schlissel M. S., Rajewsky K. and Behrens T. W. (2005): Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol., 3, e82.
53. Vuillier F., Dumas G., Magnac C., Prevost M. C., Lalanne A. I., Oppezzo P., Melanitou E., Dighiero G. and Payelle-Brogard B. (2005): Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains. Blood, 105, 2933-2940.
54. Wienands J., Larbolette O. and Reth M. (1996): Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc. Natl. Acad. Sci. USA, 93, 7865-7870.
55. Zou X., Piper T. A., Smith J. A., Allen N. D., Xian J. and Bruggemann M. (2003): Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. J. Immunol., 170, 1354-1361.